Qingdao Gehua Pharmaceutical and Healthcare Products Expo 2025

Exhibition Introduction

The 117th Qingdao Gehua Pharmaceutical and Healthcare Products Expo 2025 will take place from July 9–10, 2025 at the Qingdao International Convention and Exhibition Center. The expo will feature a wide array of OTC drugs, traditional Chinese and Western medicines, health supplements, nutrition foods, wellness products, medical equipment, personal care items, and pharmaceutical packaging solutions. Hosted by Gehua Expo, a leader in the healthcare exhibition sector since 2004 with a database of over 300,000 verified distributors, this influential event serves as a vital marketplace for branding, product promotion, business networking, and agent recruitment within China’s thriving medical and health industry.

Range of Exhibition

• Pharmaceutical Products:
  Approved OTC drugs, traditional Chinese medicine, Western medicine, ethnic medicine, and biopharmaceuticals.
• Health & Wellness Products:
  Nutritional supplements, functional foods, herbal tonics, health drinks, natural health care products, specialty nutrition goods, beauty wellness items.
• TCM & Herbal Health:
  Herbal medicines, decoction pieces, moxibustion tools, and traditional Chinese wellness treatments.
• Household Medical Equipment:
  Home therapy devices, diagnostic instruments, health monitoring equipment, rehabilitation tools, wellness and beauty instruments.
• Preventive Health & Innovation:
  Public health supplies, epidemic prevention materials, biotech innovations.
• Sexual Wellness & Personal Care:
  Sexual health products, family planning items, adult care supplies.
• Pharmaceutical Machinery & Packaging:
  Drug production machines, drying equipment, packaging machinery, and medical-grade packaging materials and technologies.

Target Audience

Pharmaceutical manufacturers, health product distributors, wellness product retailers, medical professionals, traditional medicine practitioners, healthcare suppliers, biotech researchers, health and wellness industry investors, regulatory bodies, health industry consultants